Pulike Biological Engineering

Pulike Biological Engineering Quick Ratio

The Quick Ratio (Acid Test) of Pulike Biological Engineering (603566.SS) as of Nov 5, 2026 is 0.04. In the previous year, Quick Ratio (Acid Test) was 2.18 — a change of -98.38% (lower).

Quick Ratio

0.04

YoY

-98.38%

Last updated:

Quick Ratio (Acid Test) of Pulike Biological Engineering is 2025 0.04 . Quick Ratio (Acid Test) of Pulike Biological Engineering was 2024 2.18 . It decreases by -98.38% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulike Biological Engineering Stock analysis

What does Pulike Biological Engineering do? Pulike Biological Engineering Inc generates revenue through the research, development, manufacturing, and sale of veterinary biological products and chemical medicines. The company produces vaccines and antibodies for preventing and controlling epidemic diseases in poultry and livestock, alongside chemical medicines used in treating such diseases. Its primary customers are animal health providers and agricultural enterprises requiring disease prevention and treatment solutions for poultry and livestock. The business focuses on the veterinary biological products segment, including vaccines and antibodies, and the chemical medicines segment for livestock and poultry health management. The company's product portfolio includes veterinary biological products such as vaccines and antibodies, which are applied in the prevention and control of infectious diseases in poultry and livestock. Chemical medicines are primarily used for treating epidemic diseases affecting poultry and livestock. Pulike Biological Engineering Inc targets agricultural enterprises and animal health sectors as key market segments, delivering solutions for disease management in the livestock and poultry industries. Pulike Biological Engineering Inc's revenue streams are derived from the sale of veterinary biological products and chemical medicines. The company's veterinary biological products segment encompasses vaccines and antibodies for preventing and controlling infectious diseases in poultry and livestock. Chemical medicines are sold for treating epidemic diseases in the same sectors. The business serves agricultural enterprises and animal health providers seeking comprehensive disease management solutions for poultry and livestock health. Pulike Biological Engineering is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulike Biological Engineering stock

Quick Ratio (Acid Test) of Pulike Biological Engineering is 0.04 in 2025.

Quick Ratio (Acid Test) of Pulike Biological Engineering changed from 2.18 to 0.04, representing a -98.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Pulike Biological Engineering since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Pulike Biological Engineering with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Pulike Biological Engineering

All Key Metrics — Pulike Biological Engineering